IBDEI1IM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25704,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25704,1,2,0)
 ;;=2^90875
 ;;^UTILITY(U,$J,358.3,25704,1,3,0)
 ;;=3^Indiv Psychophysiological Tx w/ Biofeedback,30 min
 ;;^UTILITY(U,$J,358.3,25705,0)
 ;;=90876^^96^1186^8^^^^1
 ;;^UTILITY(U,$J,358.3,25705,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25705,1,2,0)
 ;;=2^90876
 ;;^UTILITY(U,$J,358.3,25705,1,3,0)
 ;;=3^Indiv Psychophysiological Tx w/ Biofeedback,45 min
 ;;^UTILITY(U,$J,358.3,25706,0)
 ;;=90832^^96^1186^1^^^^1
 ;;^UTILITY(U,$J,358.3,25706,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25706,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,25706,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,25707,0)
 ;;=90834^^96^1186^2^^^^1
 ;;^UTILITY(U,$J,358.3,25707,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25707,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,25707,1,3,0)
 ;;=3^Psychotherapy 38-52 min
 ;;^UTILITY(U,$J,358.3,25708,0)
 ;;=90837^^96^1186^3^^^^1
 ;;^UTILITY(U,$J,358.3,25708,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25708,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,25708,1,3,0)
 ;;=3^Psychotherapy 53-89 min
 ;;^UTILITY(U,$J,358.3,25709,0)
 ;;=90849^^96^1186^9^^^^1
 ;;^UTILITY(U,$J,358.3,25709,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25709,1,2,0)
 ;;=2^90849
 ;;^UTILITY(U,$J,358.3,25709,1,3,0)
 ;;=3^Multiple Family Psychotherapy
 ;;^UTILITY(U,$J,358.3,25710,0)
 ;;=J1631^^96^1187^14^^^^1
 ;;^UTILITY(U,$J,358.3,25710,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25710,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,25710,1,3,0)
 ;;=3^Haloperidol Decanoate,per 50 mg
 ;;^UTILITY(U,$J,358.3,25711,0)
 ;;=97545^^96^1187^46^^^^1
 ;;^UTILITY(U,$J,358.3,25711,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25711,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,25711,1,3,0)
 ;;=3^Work Hardening/Conditioning,Init 2 hrs
 ;;^UTILITY(U,$J,358.3,25712,0)
 ;;=97546^^96^1187^47^^^^1
 ;;^UTILITY(U,$J,358.3,25712,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25712,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,25712,1,3,0)
 ;;=3^Work Hardening/Conditioning,ea addl hr
 ;;^UTILITY(U,$J,358.3,25713,0)
 ;;=97537^^96^1187^4^^^^1
 ;;^UTILITY(U,$J,358.3,25713,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25713,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,25713,1,3,0)
 ;;=3^Community/Work Reintegration per 15 min
 ;;^UTILITY(U,$J,358.3,25714,0)
 ;;=97532^^96^1187^3^^^^1
 ;;^UTILITY(U,$J,358.3,25714,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25714,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,25714,1,3,0)
 ;;=3^Cognitive Skills Development,ea 15 min
 ;;^UTILITY(U,$J,358.3,25715,0)
 ;;=97533^^96^1187^34^^^^1
 ;;^UTILITY(U,$J,358.3,25715,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25715,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,25715,1,3,0)
 ;;=3^Sensory Integrative Techniques,per 15 min
 ;;^UTILITY(U,$J,358.3,25716,0)
 ;;=H0004^^96^1187^16^^^^1
 ;;^UTILITY(U,$J,358.3,25716,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25716,1,2,0)
 ;;=2^H0004
 ;;^UTILITY(U,$J,358.3,25716,1,3,0)
 ;;=3^Ind Counseling & Therapy, per 15 min
 ;;^UTILITY(U,$J,358.3,25717,0)
 ;;=H0046^^96^1187^23^^^^1
 ;;^UTILITY(U,$J,358.3,25717,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25717,1,2,0)
 ;;=2^H0046
 ;;^UTILITY(U,$J,358.3,25717,1,3,0)
 ;;=3^PTSD Group
 ;;^UTILITY(U,$J,358.3,25718,0)
 ;;=96119^^96^1187^18^^^^1
 ;;^UTILITY(U,$J,358.3,25718,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25718,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,25718,1,3,0)
 ;;=3^Neuropsych Test by tech,per hr
 ;;^UTILITY(U,$J,358.3,25719,0)
 ;;=96402^^96^1187^17^^^^1
 ;;^UTILITY(U,$J,358.3,25719,1,0)
 ;;=^358.31IA^3^2
